Yunlin Jiang

机构：Shanghai University of Traditional Chinese Medicine, Yueyang Hospital · ORCID：0000-0002-4188-2498

发表论文 13 篇 · 总被引 49 次 · h-index 4

代表论文

• Impacts of systemic treatments on health-related quality of life for patients with metastatic colorectal cancer: a systematic review and network meta-analysis (2024 · BMC Cancer · 被引 15)
• Economic evaluation of NALIRIFOX vs. nab-paclitaxel and gemcitabine regimens for first-line treatment of metastatic pancreatic ductal adenocarcinoma from U.S. perspective (2024 · Cost Effectiveness and Resource Allocation · 被引 10)
• Cost-effectiveness analysis of atezolizumab in patients with non-small-cell lung cancer ineligible for treatment with a platinum-containing regimen: a United Kingdom health care perspective (2023 · Frontiers in Public Health · 被引 5)
• A network meta-analysis of efficacy and safety for first-line and maintenance therapies in patients with unresectable colorectal liver metastases (2024 · Frontiers in Pharmacology · 被引 4)
• Racial, ethnic, sex, and age representation in clinical trials of radiopharmaceutical tumor therapy: a systematic review and meta-analysis (2025 · BMC Cancer · 被引 3)
• Sotorasib versus Docetaxel for treatment of US and Chinese patients with advanced non-small-cell lung cancer with KRAS p.G12C-mutated: A cost-effectiveness analysis to inform drug pricing (2023 · Medicine · 被引 3)